EyeGate Pharma Discusses Early Clinical Trials Success, Promising Pipeline, and Partnership Payouts
Archived series ("Inactive feed" status)
When? This feed was archived on January 08, 2019 01:44 (). Last successful fetch was on October 31, 2018 00:37 ()
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 213816926 series 1576962
Published Jan 6 2017
EyeGate CEO Stephen From reports positive results of Phase Ia/IIb trials of EGP-437, regulatory progress for its Ocular bandage gel, and potential fundraising plans.
365 episodes